gene expression analysis
Based on growing evidence that the test provides information beyond other marketed breast cancer assays, the company is planning a commercial launch next year.
BeiGene Updates Phase III Data, Biomarker Analysis for Anti-PD-1 Drug in Nasopharyngeal Cancer
The analysis suggests tislelizumab plus chemo may be a first-line option for advanced patients, with a certain biomarker subgroup deriving the greatest benefit.
The Israeli firm's ENLIGHT test uses transcriptome sequencing plus functional drug interaction data to match more patients to drugs compared to current methods.
RxPONDER Update Yields No Clear Guidance on Chemo Decisions for Younger Breast Cancer Patients
Premium
A large, randomized trial exploring the benefit of adding chemo to endocrine therapy for premenopausal women with Oncotype DX scores of 0 to 25 will likely be needed.
NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project
The partners will use NanoString's nCounter and CAR-T Characterization Panel to ID molecular features that make CAR T-cell therapies more effective.